Membership Overview
Browsing articles in "Additional Neurology Topics"


Antidepressants and Risk for Autism, ADHD
May 12, 2017   

Recently published studies suggests that mothers' use of antidepressants during early pregnancy does not increase the risk of their children developing autism or attention deficit hyperactivity disorder, conditions previously associated with these medications....
 Continue reading (Members only)
First Drug Approved to Treat Tardive Dyskinesia
April 12, 2017   

The U.S. Food and Drug Administration (FDA) has approved valbenazine, trade name Ingrezza, for the treatment of tardive dyskinesia...
 Continue reading
Concussion in Children: New Data
January 11, 2017   

New studies address the association between early exercise following acute concussion and persistent postconcussive symptoms in children and adolescents as well as auditory biological markers of concussion in children.
 Continue reading (Members only)
Collaborative Care for Persistent Postconcussive Symptoms in Adolescents
December 8, 2016   

Sports-related concussions are often associated with postconcussive psychological symptoms, yet there is no evidence-based treatment for postconcussive symptoms in children and adolescents. A recent study tested a collaborative care intervention model...
 Continue reading (Members only)
Glia-Mediated Brain Inflammation after Repeated Concussions Detected In Vivo
December 1, 2016   

Microglia, the immune cells of the central nervous system, play a primary role in the brain’s response to injury and neurodegenerative processes. Single and repeated traumatic brain injuries may result in microglial activation...
 Continue reading (Members only)
Anticonvulsant-Induced Psychiatric Symptoms in Patients With Epilepsy
September 26, 2016   

As many as 30–50% of patients with epilepsy have psychiatric, behavioral, cognitive, or social problems, which in some cases may be related to the disease state, the medications, or both. Two recent publications—one a report of original research, the other a review—address this often overlooked clinical issue.
 Continue reading
FDA Alert: Medication and Medical Device Approvals
September 12, 2016   

The US FDA has approved the marketing of computerized cognitive tests to assess for possible concussions, granted tentative approval for Trokendi XR for migraine prevention, and approved abuse-deterrent Troxyca ER for severe pain management.
 Continue reading (Members only)
Most Children With TBI Present to Primary Care, Not Emergency Department
June 23, 2016   

A four-year study recently published by researchers from the Children’s Hospital of Philadelphia (CHOP) and the U.S. Centers for Disease Control and Prevention (CDC) found that 81.9% of children had their first concussion visit within primary care. The Children’s Hospital of Philadelphia encompasses over 50 locations including 31 primary care centers, 14 specialty care center, 2 emergency departments (ED), 2 urgent care centers, and a 535-bed inpatient hospital. Researchers examined...
 Continue reading (Members only)
FDA Alerts: Pimavanserin, Vortioxetine, Aripiprazole, and Olanzapine
May 18, 2016   

Recent updates from the FDA include the approval of pimavanserin to treat psychosis in Parkinson's disease, a change in brand name for vortioxetine, and side effect warnings for aripiprazole and olanzapine.
 Continue reading (Members only)
Novel MRI Screening Is Sensitive to Intracranial Hemorrhage for Well-Appearing Infants at Risk for Abusive Head Trauma
April 27, 2016   

Abusive head trauma (AHT) in infants, if misdiagnosed, can result in serious medical consequences, even death. In a 1999 study, 31% of infants diagnosed with AHT had been evaluated by a physician after the injury occurred, but were originally misdiagnosed as having viral gastroenteritis and viral syndrome. Of the five deaths in the study, four were considered to be preventable...
 Continue reading
Top of Page